The antifungal drugs market is poised for significant growth in the coming years, driven largely by an increasing global incidence of fungal infections and advancements in medical treatments. With a market value of USD 15.35 billion in 2023, the industry is expected to expand at a steady compound annual growth rate (CAGR) of 3.7% from 2024 to 2032, potentially reaching USD 21.28 billion by the...